These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 26058720)

  • 41. Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?
    Dorian P; Burk C; Mullin CM; Bubien R; Godejohn D; Reynolds MR; Lakkireddy DR; Wimmer AP; Bhandari A; Spertus J
    Am Heart J; 2013 Aug; 166(2):381-387.e8. PubMed ID: 23895823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    O'Brien EC; Holmes DN; Ansell JE; Allen LA; Hylek E; Kowey PR; Gersh BJ; Fonarow GC; Koller CR; Ezekowitz MD; Mahaffey KW; Chang P; Peterson ED; Piccini JP; Singer DE
    Am Heart J; 2014 Apr; 167(4):601-609.e1. PubMed ID: 24655711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of patient perception of their prevailing rhythm: a comparative analysis of monitor data and questionnaire responses in patients with atrial fibrillation.
    Garimella RS; Chung EH; Mounsey JP; Schwartz JD; Pursell I; Gehi AK
    Heart Rhythm; 2015 Apr; 12(4):658-65. PubMed ID: 25595926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry.
    Proietti M; Vitolo M; Harrison SL; Lane DA; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Boriani G; Lip GYH;
    Clin Res Cardiol; 2022 Jan; 111(1):70-84. PubMed ID: 34448931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.
    Ikemura N; Kohsaka S; Kimura T; Ueda I; Katsumata Y; Nishiyama T; Aizawa Y; Tanimoto K; Momiyama Y; Akaishi M; Mitamura H; Fukuda K; Spertus JA; Takatsuki S
    JAMA Netw Open; 2019 Mar; 2(3):e191145. PubMed ID: 30924896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New classification scheme for atrial fibrillation symptom severity and burden.
    Koci F; Forbes P; Mansour MC; Heist EK; Singh JP; Ellinor PT; Ruskin JN
    Am J Cardiol; 2014 Jul; 114(2):260-5. PubMed ID: 24878121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis--data from the German Competence Network on Atrial Fibrillation.
    von Eisenhart Rothe A; Hutt F; Baumert J; Breithardt G; Goette A; Kirchhof P; Ladwig KH
    Europace; 2015 Sep; 17(9):1354-62. PubMed ID: 25825454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.
    Spertus J; Dorian P; Bubien R; Lewis S; Godejohn D; Reynolds MR; Lakkireddy DR; Wimmer AP; Bhandari A; Burk C
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):15-25. PubMed ID: 21160035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired quality of life in patients with intermittent atrial fibrillation.
    Nazlı C; Kahya Eren N; Yakar Tülüce S; Koçağra Yağız İG; Kılıçaslan B; Kocabaş U
    Anatol J Cardiol; 2016 Apr; 16(4):250-5. PubMed ID: 26168457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment strategies and subsequent changes in the patient-reported quality-of-life among elderly patients with atrial fibrillation.
    Miura K; Ikemura N; Kimura T; Katsumata Y; Ueda I; Tanimoto K; Ohki T; Shinmura D; Negishi K; Fukuda K; Takatsuki S; Kohsaka S
    Am Heart J; 2020 Apr; 222():83-92. PubMed ID: 32028139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study.
    Vermond RA; Crijns HJ; Tijssen JG; Alings AM; Van den Berg MP; Hillege HL; Van Veldhuisen DJ; Van Gelder IC; Rienstra M;
    Europace; 2014 Oct; 16(10):1417-25. PubMed ID: 24938627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Electrical Cardioversion on Quality of Life for the Treatment of Atrial Fibrillation.
    Sandhu RK; Smigorowsky M; Lockwood E; Savu A; Kaul P; McAlister FA
    Can J Cardiol; 2017 Apr; 33(4):450-455. PubMed ID: 28129962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    O'Brien EC; Simon DN; Allen LA; Singer DE; Fonarow GC; Kowey PR; Thomas LE; Ezekowitz MD; Mahaffey KW; Chang P; Piccini JP; Peterson ED
    Am Heart J; 2014 Oct; 168(4):487-94. PubMed ID: 25262258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychopathology and symptoms of atrial fibrillation: implications for therapy.
    Gehi AK; Sears S; Goli N; Walker TJ; Chung E; Schwartz J; Wood KA; Guise K; Mounsey JP
    J Cardiovasc Electrophysiol; 2012 May; 23(5):473-8. PubMed ID: 22429764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
    De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
    Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptom Under-Recognition of Atrial Fibrillation Patients in Consideration for Catheter Ablation: A Report From the KiCS-AF Registry.
    Katsumata Y; Kohsaka S; Ikemura N; Ueda I; Hashimoto K; Yamashita T; Miyama H; Fujisawa T; Kimura T; Tanimoto K; Momiyama Y; Suzuki M; Fukuda K; Takatsuki S
    JACC Clin Electrophysiol; 2021 May; 7(5):565-574. PubMed ID: 33358669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.
    Ahmed S; Ranchor AV; Crijns HJ; Van Veldhuisen DJ; Van Gelder IC;
    Europace; 2010 Jun; 12(6):785-91. PubMed ID: 20200016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of atrial fibrillation on quality of life (AFEQT) questionnaire: A Turkish validity and reliability study.
    Güneş F; Boyraz S
    Turk Kardiyol Dern Ars; 2021 Apr; 49(3):223-232. PubMed ID: 33847271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe.
    Schnabel RB; Pecen L; Rzayeva N; Lucerna M; Purmah Y; Ojeda FM; De Caterina R; Kirchhof P
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mobile Electrocardiogram Monitoring and Health-Related Quality of Life in Patients With Atrial Fibrillation: Findings From the iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology (iHEART) Study.
    Caceres BA; Hickey KT; Bakken SB; Biviano AB; Garan H; Goldenthal IL; Koleck TA; Masterson-Creber R; Turchioe MR; Jia H
    J Cardiovasc Nurs; 2020; 35(4):327-336. PubMed ID: 32015256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.